Healthcare / Health Information ServicesNasdaqGS
$10.80
+0.21 (+1.98%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $25.2M · quality 69.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$226M
P/E
18.3x
↓EV/EBITDA
8.9x
↓ROE
10.8%
↑Gross Margin
78.7%
↑Debt/Equity
0.05
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
-4.5%
FCF CAGR
-7.3%
FCF margin
18.0%
FCF / Net income
1.59x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $139.7M · net income $15.9M · FCF $25.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $139.7M | $139.7M | $137.7M | $139.0M | $134.5M | $142.2M | $148.2M | $160.3M | $169.5M | $171.2M | $179.6M | $189.6M | $200.3M | $209.8M | $219.7M | $233.7M | $233.3M | $289.7M |
| Net Income | $15.9M | $15.9M | $15.0M | $15.7M | $21.9M | $-22.2M | $-44.2M | $-10.8M | $-1.5M | $-15.3M | $14.0M | $80.2M | $20.7M | $27.5M | $27.0M | $83.8M | $77.9M | $67.6M |
| EBITDA | $23.6M | $23.6M | $24.2M | $26.3M | $11.1M | $-17.3M | $-13.6M | $-6.6M | $7.6M | $22.3M | $35.1M | $39.1M | $44.8M | $60.7M | $64.0M | $71.2M | $81.3M | $99.3M |
| EPS | 0.75 | 0.75 | 0.73 | 0.77 | 1.09 | -1.14 | -2.32 | -0.56 | — | — | — | 3.98 | 0.94 | 1.25 | 1.20 | 3.72 | 3.45 | 2.90 |
| Gross Margin | 78.7% | 78.7% | 79.1% | 80.5% | 79.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 14.4% | 14.4% | 14.6% | 15.7% | 5.6% | -19.5% | -15.3% | -9.9% | -1.9% | 6.3% | 12.3% | 13.2% | 14.1% | 21.7% | 20.8% | 22.2% | 24.5% | 19.8% |
| Net Margin | 11.4% | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | -29.8% | -6.7% | -0.9% | -8.9% | 7.8% | 42.3% | 10.4% | 13.1% | 12.3% | 35.9% | 33.4% | 23.3% |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | 0.05 | 0.05 | 0.06 | 0.07 | 0.09 | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | — |
| Current Ratio | 1.09 | 1.09 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $25.2M | $25.2M | $25.7M | $22.8M | $2.7M | $3.6M | $22.7M | $6.9M | $4.4M | $6.3M | $31.3M | $36.3M | $33.9M | $40.0M | $62.9M | $74.5M | $70.7M | $84.6M |
| Returns | ||||||||||||||||||
| ROE | 10.8% | 10.8% | 9.7% | 9.6% | 12.8% | -12.8% | -22.2% | -4.3% | -0.5% | -5.3% | 4.3% | 24.3% | 7.4% | 10.2% | 10.7% | 33.8% | 42.2% | 42.5% |
| Valuation | ||||||||||||||||||
| P/E | 18.31 | 18.31 | 21.96 | 19.73 | 7.67 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 8.86 | 8.86 | 12.77 | 10.96 | 13.20 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| P/B | 1.55 | 1.55 | 2.13 | 1.89 | 0.98 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 1.5% | 1.5% | -1.0% | 3.3% | — | -4.1% | -7.6% | -5.4% | -1.0% | -4.7% | -5.3% | -5.3% | -4.5% | -4.5% | -6.0% | 0.2% | -19.5% | — |
| EPS Growth | 2.7% | 2.7% | -5.2% | -29.4% | — | 50.9% | -314.3% | — | — | — | — | 323.4% | -24.8% | 4.2% | -67.7% | 7.8% | 19.0% | — |
| Dividend Yield | 11.6% | 11.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
8.5%
EPS terminal req.
$0.96
Spread vs growth
-5.8%
5Y implied EPS CAGR
9.1%
EPS terminal req.
$1.16
Spread vs growth
-6.4%
10Y implied EPS CAGR
9.6%
EPS terminal req.
$1.87
Spread vs growth
-6.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-21.8%
Start / end P/E
22.2x → 14.4x
EPS bridge
0.73 → 0.75
Residual
-1.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.